NEW YORK - A blood mismatch between a pregnant woman and her fetus may double the risk of schizophrenia, according to the results of a new study. But all of the children in the study were born before ...

Only half of pregnant women worldwide who need a treatment developed over 50 years ago to prevent Rh disease--an often-fatal condition in fetuses and newborns that is now exceedingly rare in the ...

NEW YORK, NY (Aug. 10) -- Only half of pregnant women worldwide who need a treatment developed over 50 years ago to prevent Rh disease--an often-fatal condition in fetuses and newborns that is now ...

In March, the U.S. FDA reported a major shortage of Rhogam, the anti-D immune globulin most widely used to prevent Rh factor incompatibility in pregnancy. Without treatment, second and subsequent ...

Hemolytic disease of the newborn is a type of anemia that begins during pregnancy. It can cause serious illness in a newborn, but it may be diagnosed during prenatal screening and treated to avoid ...

To evaluate whether Rh-positive preterm newborn infants born to Rh-negative mothers treated with prophylactic anti-D immunoglobulins exhibited signs of hemolytic reaction, including anemia and ...

An early diagnosis followed by preventive management can significantly diminish the threats posed by Rh incompatibility, making it a manageable condition rather than a frightening one.Understanding ...

A special immune treatment may not be necessary until after the first trimester of pregnancy, according to a new Penn State and University of Pennsylvania study. The researchers said their results ...

Only half of pregnant women worldwide who need a 50-year-old treatment that prevents an often-fatal disease in fetuses and newborns receive it, researchers have found. Only half of pregnant women ...